Professional services group Gateley has significantly enhanced its growing trade mark practice following the acquisition of boutique IP firm Groom Wilkes & Wright LLP (GWW). GWW, which specialises in every aspect of trade mark and design law, was acquired in a move that significantly enhances the already considerable IP expertise...
WMHTIA Impact event showcases £67.3m Co-Investment and Future Opportunities for Health Tech
Leaders from across the life sciences and health technology community gathered this week for the West Midlands Health Tech Innovation Accelerator (WMHTIA) Impact Event, held as part of Life Sciences Week 2025. The event, focused on Impact, Insights & the Future of Health Tech, highlighted the achievements of the two-year...
Medilink Midlands recognised with Outstanding Contribution Award at Life Sciences Week
On Thursday 11 September, Medilink Midlands was honoured to receive the Outstanding Contribution to Life Sciences Award at the Life Sciences Gala Dinner & Awards, part of Life Sciences Week 2025 – a week-long programme of events celebrating the region’s life sciences excellence. The Gala Dinner brought together organisations and...
Medilink Midlands Innovation Day 2025: Life sciences community unites at Villa Park
Medilink Midlands has celebrated another hugely successful Innovation Day, the Midlands' flagship life sciences and medtech conference and exhibition. Held on Wednesday 17 September at Villa Park, Birmingham, the event brought together over 250 delegates for a full day of sector insight, networking, exhibitions, and expert-led workshops. As part of...
WMHTC announces leadership transition and ownership transfer to Medilink Midlands
WMHTC today announced a significant transition in its leadership and ownership structure. The current Executive Chair of WMHTC, David Kidney, will be stepping down, marking the end of a pivotal chapter in the organisation’s journey. Effective 1 October 2025, WMHTC will be operated under the stewardship of Medilink Midlands. This...
Derby based Pennine healthcare hosts government whip to showcase ROTL success and future industry opportunities
Pennine Healthcare, one of the UK’s leading employee-owned medical device manufacturers, was proud to welcome Sir Nicholas Dakin, Government Whip, Lord Commissioner of HM Treasury, and Parliamentary Under-Secretary (Ministry of Justice), to its Derby headquarters last week. The visit highlighted the success of Pennine’s Release on Temporary Licence (ROTL) Scheme,...
Upperton win Pharma Contract Services Company of the Year at the Pharma Industry Awards UK 2025
Nottingham, UK – 11th September 2025 – Upperton Pharma Solutions has added another impressive award to a growing list of achievements, winning the award for Pharma Contract Services Company of the Year at the Pharma Industry Awards UK and nominated finalist for Pharma Company of the Year. This year marks...
Health Innovation East Midlands and Medilink Midlands confirm renewed collaboration to drive life sciences and innovation
Health Innovation East Midlands and Medilink Midlands are delighted to confirm the signing of a renewed Memorandum of Understanding, marking a strengthened collaboration to drive life sciences and health innovation across the East Midlands. Together, we will develop a joint proposition for consideration by the East Midlands Combined Authority and...
Haughton Design Appoints Dr Ash Ghadar as CEO to Accelerate Growth in Pharma and MedTech
Haughton Design, a leading UK-based product design consultancy specialising in medical devices, drug delivery systems and healthcare technology, has appointed Dr Ash Ghadar as Chief Executive Officer (CEO) to lead the company’s next phase of growth in the MedTech and Pharmaceutical sectors. Dr Ghadar joined Haughton Design in January 2025 as...
Pioneer and AbbVie team up on a Golden Ticket to accelerate game-changing innovations in human health
Pioneer Group, a specialist in life science infrastructure and venture building, has once again teamed up with global biopharmaceutical company AbbVie to launch a Golden Ticket programme designed to accelerate companies developing novel, transformational therapies and innovations for immunology, oncology, neurology, eye care, aesthetics, or other specialities including obesity, GI and...